| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/25/2008 | US20080234185 Use of Dmbt1 for Capturing Sulphate and Phosphate Group Exposing Agents |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080234175 Reaction mixture of a complex of an negative-sense NS1 protein of influenza virus, or a douple stranded (ds)RNA binding fragment of it, and a dsRNA that binds the protein; targets for drug design; small scale and/or high-throughput screening for inhibitors of interactions between NS1A or NS1B, and dsRNA, |
| 09/25/2008 | US20080234139 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 09/25/2008 | US20080234138 TP53 gene expression and uses thereof |
| 09/25/2008 | US20080234137 Assay Method for Group Transfer Reactions |
| 09/25/2008 | US20080233642 Mammalian immortalized liver cell |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233635 particle differentiation device; identifying and separating sperm cells according to chromosomal complement; photomultiplier tube converts light from light emission source into one differentiation signal; cattle, sheep, and/or horse in vitro fertilization and veterinary medicine |
| 09/25/2008 | US20080233632 Process for Labeling and Purification of Nucleic Acids of Interest Present in a Biological Sample to be Treated in a Single Reaction Vessel |
| 09/25/2008 | US20080233610 by administering at least one or a plurality of potency-determining factors; not c-Myc and Klf4; at least one putative potency-determining factor is Oct-4, Sox2 and at least one of Nanog and Lin28 |
| 09/25/2008 | US20080233609 Spirolactam Targeting Compounds and Related Compounds |
| 09/25/2008 | US20080233608 Genes and proteins involved in lipid remodeling of gpi-anchored proteins and the use thereof |
| 09/25/2008 | US20080233607 for the functional maintenance of cells, particularly anchorage-dependent cells; for the long term culture of hepatocytes in vitro |
| 09/25/2008 | US20080233606 Use of raman spectroscopy in enzyme activity assays |
| 09/25/2008 | US20080233605 assaying glycated protein, fructosyl peptide, or fructosyl amino acid which can be performed with reduced effect of fructosyl lysine compounds; by causing an enzyme to act specifically on fructosyl peptide or fructosyl amino acid at a pH of 4.0 to 7.0 |
| 09/25/2008 | US20080233604 Methods For Identifying Compounds Capable of Modulating the Hydrolase Activity of Clca Protein |
| 09/25/2008 | US20080233603 Fluorine NMR spectroscopy for biochemical screening |
| 09/25/2008 | US20080233602 Detecting and profiling molecular complexes |
| 09/25/2008 | US20080233599 Immunogenic glycopeptides, screening, preparation and uses |
| 09/25/2008 | US20080233597 measuring the levels of human lipocalin-type prostaglandin D synthase in a sample such as a body fluid as an index |
| 09/25/2008 | US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 09/25/2008 | US20080233595 Method for diagnosing intertility |
| 09/25/2008 | US20080233593 of the pre-processing such as the control of homogenization conditions; three primary processes: pre-processing, nucleic acid amplification, and detection |
| 09/25/2008 | US20080233592 Detecting the activity of and screening acceptor substrates, inhibitors, or activators of enzymes catalyzing group transfer reactions to facilitate the development of more selective and therapeutic drugs |
| 09/25/2008 | US20080233591 enables assessment of dynamic variations in a mixed population of organisms using affinity aided solution hybridization combined with resolution providing fractionation; very sensitive; allow quantitative detection of polynucleotide sequences present in diminutive amounts |
| 09/25/2008 | US20080233590 Device For the Analysis of Liquid Samples |
| 09/25/2008 | US20080233589 If a molecular interaction occurs, then the heterologous polypeptide fragments are able to associate and produce a detectable signal; allows for real time enhanced imaging of biomolecule interactions both in vitro and in vivo |
| 09/25/2008 | US20080233588 Using RNA probes to quantify and detect preferential nucleotide sequences in sample; bioassay; bioluminescent signalling system comprises luciferase and luciferin |
| 09/25/2008 | US20080233587 buffer formulation allows for minimal sample purification; direct buffer comprises at least 5 PCR primer pairs, Tris-HCl at 10-16 mM, KCl at 25-75 mM, dNTPs at 200-400 uM each dNTP, BSA at 160-960 ug/ml, AmpliTaq Gold polymerase at 2 U-8 U, MgCl2 at 1.25-2.2 mM, and DMSO at 0-4%. |
| 09/25/2008 | US20080233586 Methods for preparing and preforming analysis |
| 09/25/2008 | US20080233585 Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| 09/25/2008 | US20080233584 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 09/25/2008 | US20080233583 Biomarkers for preeclampsia |
| 09/25/2008 | US20080233582 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
| 09/25/2008 | US20080233581 Nucleic acid; use identifying the enzyme inhibitors which are used as antitumor agents; detection of cells expressing the enzyme |
| 09/25/2008 | US20080233580 transgenic mouse model which allows for the simultaneous, tissue-specific and temporally-controlled regulation of transgene expression and can be used as a tool to investigate the consecutive steps involved in initiation and progression of certain diseases such as cancer, but particularly lung cancer |
| 09/25/2008 | US20080233579 Primer set for detecting overexpression of katp channel and kit comprising said primer set |
| 09/25/2008 | US20080233578 presence or absence of a mutation in a nucleic acid sequence is judged by a product formed; amplification of a nucleic acid in which a mismatch is present can be selectively suppressed by allowing it to contact with a single-stranded DNA-binding protein at the time of the nucleic acid amplification |
| 09/25/2008 | US20080233577 substance is offered to a set of candidate ligands, and the unbonded ligands are separated out by a cross-flow filtration; parameters are varied; candidate ligands whose bond with the target substance was dissolved by the parameter variation are collected in separate fractions and separately multiplied |
| 09/25/2008 | US20080233576 Recursive feature elimination (RFE); gene expression data processing; DNA microarrays; for diagnosis of renal cancer |
| 09/25/2008 | US20080233575 Methods for increasing accuracy of nucleic scid sequencing |
| 09/25/2008 | US20080233574 Use of mRNA transcripts, and variation in transcript levels for the identification of quantitative trait loci pertaining to a desired trait within an organism; exhibiting a measurable response to an environmental stimulus or phenotype of interest |
| 09/25/2008 | US20080233573 Gene expression profiling for identification, monitoring and treatment of transplant rejection |
| 09/25/2008 | US20080233572 Methods and compositions for the detection and quantification of e.coli and enterococcus |
| 09/25/2008 | US20080233571 Identifying a compound controlling gene expression; formation of synaptic connections at excitatory neurons; localization of Narp in excitatory neurons; nervous system disorders; gene therapy; AMPA receptors |
| 09/25/2008 | US20080233570 Oligonucleotide primer for rapid identification and quantification of microorganisms; blood toxemia; obtaining amplification products using primer pairs that hybridize to ribosomal RNA and housekeeping gene; comparing base compositions to known amplification products of sepsis-causing bacteria |
| 09/25/2008 | US20080233569 Detection of Extracellular Tumor-Associated Nucleic Acid in Blood Plasma or Serum Using Nucleic Acid Amplification Assays |
| 09/25/2008 | US20080233568 Detection of tumors in blood plasma and hybridization of oncogenes or amplification of nucleic acids for mutant DNA; Extraction; use in identifying, diagnosing, monitoring, or evaluating cancer; gel electrophoresis, hybridization, blot analysis, liquid chromatography; monoclonal antibody cancer therapy |
| 09/25/2008 | US20080233567 Companion diagnostic assays for cancer therapy |
| 09/25/2008 | US20080233566 Methods and materials for detecting mutations in quasispecies having length polymorphisms |
| 09/25/2008 | US20080233565 PKHDL1, a homolog of the autosomal recessive kidney disease gene |
| 09/25/2008 | US20080233564 Methods of Using Databases to Greate Gene-Expression Microarrays, Microarrays Greated Thereby, and Uses of the Microarrays |
| 09/25/2008 | US20080233563 Enhanced Detection of Rna Using a Panel of Truncated Gene-Specific Primers for Reverse Transcription |
| 09/25/2008 | US20080233562 dividing cells into histone deacetylase inhibitor sensitive and histone deacetylase inhibitor resistant cell; selecting gene showing high expression in sensitive tumor cell and low expression in resistant tumor cell or vice versa; provides gene for predicting efficacy of histone deacetylase inhibitor |
| 09/25/2008 | US20080233561 Method for Measuring Cytopathic Effect Due to Viral Infection in Cells Using Electric Cell-Substrate Impedance Sensing |
| 09/25/2008 | US20080233560 DNA-transfection system for the generation of infectious influenza virus |
| 09/25/2008 | US20080233559 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein |
| 09/25/2008 | US20080233558 Inhibitors of viral entry screening method |
| 09/25/2008 | US20080233557 can accurately detect mutations of rtL180M, rtM204V, rtM204I and rtV2071 within B and C domains of HBV DNA polymerase gene; kits |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233555 Homogeneous assay for enzymatic activity |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2008 | US20080233106 Markers for labour |
| 09/25/2008 | US20080233101 RNA-mediated epigenetic regulation of gene transcription |
| 09/25/2008 | US20080233098 For regulation of growth of neurons in the Central Nervous System; delivering a dominant negative RhoA to the nerve growth environment of the patient, stimulating axon growth of a damaged neuronal axon; exoenzyme C3( ADP-ribosyltransferase) or Y27632 |
| 09/25/2008 | US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs |
| 09/25/2008 | US20080233089 Modified Cells Expressing a Protein That Modulates Activity of Bhlh Proteins, and Uses Thereof |
| 09/25/2008 | US20080230399 Fructosylamine Oxidase |
| 09/25/2008 | US20080230387 Microfluidic Devices and Methods of Using Same |
| 09/25/2008 | US20080230384 Low volume electrochemical biosensor |
| 09/25/2008 | US20080230383 Apparatus for promoting liposome stability and for use in detection of preferential particle in sample; includes a membrane which includes an immobilized liposome zone |
| 09/25/2008 | DE102007013736A1 Bacteria detection in blood samples, involves providing blood sample and oxygen sensor, where oxygen concentration of sample is measured by oxygen sensor and base value of oxygen concentration is determined |
| 09/25/2008 | DE102006054789B4 Verfahren und Vorrichtung zur Behandlung biologischer Zellen auf einem Substrat Method and apparatus for treatment of biological cells on a substrate |
| 09/25/2008 | DE102005020618B4 Verfahren und Systeme zur Erweiterung, Untersuchung, Verfeinerung und Analyse von biologischen Netzwerken Methods and systems for expansion, investigation, refinement and analysis of biological networks |
| 09/25/2008 | CA2693847A1 Bladder cancer diagnosis and/or prognosis method |
| 09/25/2008 | CA2682112A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | CA2681648A1 Systems and methods for anaerobic environmental microbial compartmentalized cultivation |
| 09/25/2008 | CA2681193A1 Pericycle-specific expression of microrna167 in transgenic plants |
| 09/25/2008 | CA2681080A1 A cell-mediated immune response assay and kits therefor |
| 09/25/2008 | CA2680823A1 Biomarkers of sirtuin activity and methods of use thereof |
| 09/25/2008 | CA2680774A1 Amperometric biosensor for histamine determination |
| 09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
| 09/25/2008 | CA2680591A1 Gene expression markers for prediction of patient response to chemotherapy |
| 09/25/2008 | CA2680426A1 Assay for gene expression |
| 09/25/2008 | CA2679511A1 System and method for detection of hiv drug resistant variants |
| 09/25/2008 | CA2677852A1 Method to monitor drug efficacy in diabetic patients using an assay for 1,5-anhydro-d-glucitol |
| 09/24/2008 | EP1972936A2 Biosensor for disease diagnosis |
| 09/24/2008 | EP1972935A1 Screening method for infectious agent of prion disease |
| 09/24/2008 | EP1972928A2 Device and method for non-destructive testing of biostatic and/or biocidal properties of a photocatalytic surface coating |
| 09/24/2008 | EP1972693A1 Method and kit for detecting a target protein using a DNA aptamer |
| 09/24/2008 | EP1972692A1 Methods of producing haploid and doubled haploid oil palms |
| 09/24/2008 | EP1972690A1 Desaturase antigen of mycobacterium tuberculosis |
| 09/24/2008 | EP1972688A1 Method of amplifying nucleic acid from microorganism using nonplanar solid substrate |
| 09/24/2008 | EP1972687A1 Polynucleotides and polypeptides of human factor VII gene, SNPs |